Teva UK, a part of Teva Pharmaceutical Industries, has introduced the generic atorvastatin film-coated tablets in 10mg, 20mg, 40mg and 80mg strengths in the UK. The generic version of Pfizer's Lipitor is indicated for the treatment of ...
Tags: Teva UK, film-coated tablets, treatment of hypercholesterolaemia
Teva, a provider of generic pharmaceutical drugs, has introduced Rivastigmine capsules for generic prescription. Rivastigmine is generic equivalent to Novartis' Exelon capsules. Rivastigmine is indicated for use in the symptomatic ...
Tags: Teva, rivastigmine, Novartis'Exelon capsules
Theravectys has received regulatory clearances from France's National Security Agency and Belgium's Federal Agency for Medicines and Health Products to commence a phase I/II clinical trial of its anti-HIV therapeutic vaccine. Using the ...
Tags: Theravectys, HIV positive patients, anti-HIV therapeutic vaccine
Daiichi Sankyo has gained FDA approval to package product at its packaging facility located in Bethlehem, Pennsylvania, US. The Pennsylvania facility will package some of the company's products for cardiovascular and metabolic ...
Tags: FDA, medical product, expansion, business operations
Toppan Printing has developed a laminated packaging material that uses biomass polyethylene film (biomass PE) with a thickness of less than 40μm. The flexible packaging material, a new product in the company’s series of BIOAXX ...
Tags: Laminated Packaging Material, flexible packaging material
Merck Serono, a division of Merck, and Auxogyn have partnered to develop Early Embryo Viability Assessment (Eeva) test. Pursuant to the deal, Merck Serono will provide strategic, scientific and medical support for the development of ...
Tags: Early Embryo Viability Assessment test, eeva test, clinical development
Pharmaceutical company in the US, Merck Sharp and Dohme (MSD) has opened a new $21m packaging facility in Pandaan, Pasuruan, Indonesia, in an effort to step up its production for the Indonesian and Asian markets. The plant, which was ...
Tags: Medicine Packaging, Pharmaceutical, packaging facility
UCB has launched Neupro (Rotigotine Transdermal System) in US pharmacies for the treatment of Parkinson's disease (PD) and Restless Legs Syndrome (RLS). Neupro received the US Food and Drug Administration approval on 3 April 2012. UCB ...
Tags: Neupro, Rotigotine Transdermal System, PD, RLS
Mylan has announced the launch of Ibandronic Acid Film Coated Tablets POM, 150mg, to treat osteoporosis in the UK and Italy. The product, launched by Mylan's subsidiaries based in the UK and Italy, is the generic version of Roche's ...
Tags: Mylan, ibandronic acid, ibandronic acid film coated tablets POM
The UK Food Standards Agency(FSA)has advised people not to consume products containing DMAA(1,3-dimethylamylamine)-an ingredient used primarily in sports supplements,as it may lead to adverse health reactions. Products containing DMAA are ...
AstraZeneca and Ardelyx have signed a worldwide exclusive licensing agreement for Ardelyx's NHE3 inhibitor programme for the treatment of complications associated with end-stage renal disease (ESRD) and chronic kidney disease (CKD). The ...
Tags: RDX5791, Ardelyx, AstraZeneca, NHE3 inhibitor programme, NHE3
Linguamatics has launched a new cloud-based clinical trials text mining solution, I2E. The platform is used for mining clinical trials data for decision support in biomedical research, clinical trials study design, site selection and ...
Tags: cloud-based clinical trials, Linguamatics, clinical platform
Dilaforette has received SEK2.85m ($425m) to develop sevuparin, a new treatment for severe malaria from Vinnova, a Swedish Governmental Agency. Sevuparin is an adjunctive therapy to anti-parasite medicines to prevent the infected red ...
Tags: Dilaforette, sevuparin, severe malaria
The National Security Agency of Medicines and Health Products in France has granted marketing authorization to pSivida's ILUVIEN for the treatment of vision impairment associated with chronic diabetic macular edema (DME). The injectable, ...
Affymax has earned $50m development milestone payment from Takeda Pharmaceutical Company for the US approval of OMONTYS (peginesatide) injection. The company has also received another $5m milestone payment, which was triggered by the ...